Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Regulatory Filings 2015

Nov 4, 2015

5229_rns_2015-11-04_8dc1f281-70c1-4c3a-a7aa-e56643c0619a.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4519E

AstraZeneca PLC

04 November 2015

AstraZeneca PLC year-to-date and Q3 Results 2015

Tomorrow, Thursday, 5th November 2015, AstraZeneca PLC will release year-to-date and Q3 results for 2015 at 07:00 GMT.

An analyst presentation of the year to date and Q3 results for 2015 will take place at 12:00 GMT and will be accessible by a choice of two routes:

Audio webcast

The presentation will be available to download on the AstraZeneca Investor Relations website http://www.astrazeneca.com/investors two hours before the analyst presentation begins.

Teleconference with Q&A.  Dial in numbers:

UK (freephone):              0800 694 2370 

International:                  +44 (0) 1452 557 749    

Sweden (freephone):       0200 883 079

US (freephone):              866 977 7645    

Conference ID:  75218823

Details of the teleconference and webcast replay facilities are available on the Investor Relations section of the AstraZeneca website http://www.astrazeneca.com/investors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORPKNDBOBDDCDK